Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPC vs IPC + Doxycycline for Malignant Pleural Effusions
NCT02623959Phase 4Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Apr 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of doxycycline in malignant pleural effusion (MPE) (2 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Time to Catheter Removal at 1 month. Started Apr 2016; status: terminated.
02
Drugs
doxycycline
03
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on NCT02623959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02623959.